EDITORIALS

How Should Women With Early-Onset Endometrial Cancer Be Evaluated for Lynch Syndrome?

Noah D. Kauff

JCO Nov 20 2007: 5143–5146. First published on Oct 9 2007; 10.1200/JCO.2007.13.4940. [Full Text] [PDF]

Germline Pharmacogenetics of Tamoxifen Response: Have We Learned Enough?

Zeruesenay Desta and David A. Flockhart

JCO Nov 20 2007: 5147–5149. [Full Text] [PDF]

Bevacizumab for the Treatment of Epithelial Ovarian Cancer: Will This Be Its Finest Hour?

Stanley B. Kaye

JCO Nov 20 2007: 5150–5152. [Full Text] [PDF]

Toward Progression-Free Survival As a Primary End Point in Advanced Colorectal Cancer

Greg Yothers

JCO Nov 20 2007: 5153–5154. [Full Text] [PDF]

Duration of First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer: Less Is More in the Era of Effective Subsequent Therapies

Mark A. Socinski and Thomas E. Stinchcombe

JCO Nov 20 2007: 5155–5157. [Full Text] [PDF]

ORIGINAL REPORTS
Gynecologic Cancer
	Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial Cancer
	Karen H. Lu, John O. Schorge, Kerry J. Rodabaugh, Molly S. Daniels, Charlotte C. Sun, Pamela T. Soliman, Kristin G. White, Rajyalakshmi Luthra, David M. Gershenson, and Russell R. Broaddus
	JCO Nov 20 2007: 5158–5164. First published on Oct 9 2007; 10.1200/JCO.2007.10.8597. [Abstract] [Full Text] [PDF]
	Phase II Trial of Bevacizumab in Persistent or Recurrent Epithelial Ovarian Cancer or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
	Robert A. Burger, Michael W. Sill, Bradley J. Monk, Benjamin E. Greer, and Joel I. Sorosky
	JCO Nov 20 2007: 5165–5171. [Abstract] [Full Text] [PDF]
	ERCC1 Genotype and Phenotype in Epithelial Ovarian Cancer Identify Patients Likely to Benefit From Paclitaxel Treatment in Addition to Platinum-Based Therapy
	Stephanie Smith, Dan Su, Irene A. Rigault de la Longrais, Peter Schwartz, Manuela Puopolo, Thomas J. Rutherford, Gil Mor, Herbert Yu, and Dionyssios Katsaros
	JCO Nov 20 2007: 5172–5179. [Abstract] [Full Text] [PDF]
	Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer
	Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson, Julie Hambleton, Jakob Dupont, Howard Mackey, Jeffrey Douglas, Robert A. Burger, Deborah Armstrong, Robert Wenham, and William McGuire
	JCO Nov 20 2007: 5180–5186. [Abstract] [Full Text] [PDF] [Publisher's Note]

Breast Cancer
	Breast Cancer Treatment Outcome With Adjuvant Tamoxifen Relative to Patient CYP2D6 and CYP2C19 Genotypes
	Werner Schroth, Lydia Antoniadou, Peter Fritz, Matthias Schwab, Thomas Muerdter, Ulrich M. Zanger, Wolfgang Simon, Michel Eichelbaum, and Hiltrud Brauch
	JCO Nov 20 2007: 5187–5193. [Abstract] [Full Text] [PDF] [Chinese PDF]
	Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer
	Michail Ignatiadis, Nikos Xenidis, Maria Perraki, Stella Apostolaki, Eleni Politaki, Maria Kafousi, Efstathios N. Stathopoulos, Aliki Stathopoulou, Evi Lianidou, Grigorios Chlouverakis, Christos Sotiriou, Vassilis Georgoulias, and Dimitris Mavroudis
	JCO Nov 20 2007: 5194–5202. First published on Oct 22 2007; 10.1200/JCO.2007.11.7762. [Abstract] [Full Text] [PDF]
	Increasing Use of Contralateral Prophylactic Mastectomy for Breast Cancer Patients: A Trend Toward More Aggressive Surgical Treatment
	Todd M. Tuttle, Elizabeth B. Habermann, Erin H. Grund, Todd J. Morris, and Beth A. Virnig
	JCO Nov 20 2007: 5203–5209. First published on Oct 22 2007; 10.1200/JCO.2007.12.3141. [Abstract] [Full Text] [PDF]
	Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
	Eva S. Thomas, Henry L. Gomez, Rubi K. Li, Hyun-Cheol Chung, Luis E. Fein, Valorie F. Chan, Jacek Jassem, Xavier B. Pivot, Judith V. Klimovsky, Fernando Hurtado de Mendoza, Binghe Xu, Mario Campone, Guillermo L. Lerzo, Ronald A. Peck, Pralay Mukhopadhyay, Linda T. Vahdat, and Henri H. Roché
	JCO Nov 20 2007: 5210–5217. First published on Oct 29 2007; 10.1200/JCO.2007.12.6557. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer
	Marc Buyse, Tomasz Burzykowski, Kevin Carroll, Stefan Michiels, Daniel J. Sargent, Langdon L. Miller, Gary L. Elfring, Jean-Pierre Pignon, and Pascal Piedbois
	JCO Nov 20 2007: 5218–5224. [Abstract] [Full Text] [PDF]
	Phase II Trial of Cetuximab in Combination With Fluorouracil, Leucovorin, and Oxaliplatin in the First-Line Treatment of Metastatic Colorectal Cancer
	Josep Tabernero, Eric Van Cutsem, Eduardo Díaz-Rubio, Andrés Cervantes, Yves Humblet, Thierry André, Jean-Luc Van Laethem, Patrick Soulié, Esther Casado, Chris Verslype, Javier Sastre Valera, Giampaolo Tortora, Fortunato Ciardiello, Oliver Kisker, and Aimery de Gramont
	JCO Nov 20 2007: 5225–5232. [Abstract] [Full Text] [PDF]

Thoracic Oncology
	Phase III Trial of Two Versus Four Additional Cycles in Patients Who Are Nonprogressive After Two Cycles of Platinum-Based Chemotherapy in Non–Small-Cell Lung Cancer
	Joon Oh Park, Sang-We Kim, Jin Seok Ahn, Cheolwon Suh, Jung Shin Lee, Joung Soon Jang, Eun Kyung Cho, Sung Hyun Yang, Jin-Hyuk Choi, Dae Seog Heo, Suk Young Park, Sang Won Shin, Myung Ju Ahn, Jong Seok Lee, Young Ho Yun, Jae-Won Lee, and Keunchil Park
	JCO Nov 20 2007: 5233–5239. [Abstract] [Full Text] [PDF] [Chinese PDF]
	Prognostic and Predictive Importance of p53 and RAS for Adjuvant Chemotherapy in Non–Small-Cell Lung Cancer
	Ming-Sound Tsao, Sarit Aviel-Ronen, Keyue Ding, Davina Lau, Ni Liu, Akira Sakurada, Marlo Whitehead, Chang-Qi Zhu, Robert Livingston, David H. Johnson, James Rigas, Lesley Seymour, Timothy Winton, and Frances A. Shepherd
	JCO Nov 20 2007: 5240–5247. [Abstract] [Full Text] [PDF] [Chinese PDF]

Cost Effectiveness
	Costs and Cost-Effectiveness of a Low-Intensity Patient-Directed Intervention to Promote Colorectal Cancer Screening
	Veena Shankaran, June M. McKoy, Neal Dandade, Narissa Nonzee, Cara A. Tigue, Charles L. Bennett, and Tom D. Denberg
	JCO Nov 20 2007: 5248–5253. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Prognostic Role of Minimal Residual Disease in Mature B-Cell Acute Lymphoblastic Leukemia of Childhood
	Lara Mussolin, Marta Pillon, Valentino Conter, Matilde Piglione, Luca Lo Nigro, Paolo Pierani, Concetta Micalizzi, Salvatore Buffardi, Giuseppe Basso, Luigi Zanesco, and Angelo Rosolen
	JCO Nov 20 2007: 5254–5261. [Abstract] [Full Text] [PDF]
	Disability in Adult Survivors of Childhood Cancer: A Swedish National Cohort Study
	Anders Hjern, Frank Lindblad, and Krister K. Boman
	JCO Nov 20 2007: 5262–5266. [Abstract] [Full Text] [PDF]

Complementary Therapy
	Initiation and Discontinuation of Complementary Therapy Among Cancer Patients
	Sung-Gyeong Kim, Eun-Cheol Park, Jae-Hyun Park, Myung-Il Hahm, Jin-Hwa Lim, and Kui-Son Choi
	JCO Nov 20 2007: 5267–5274. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Desire for Information and Involvement in Treatment Decisions: Elderly Cancer Patients' Preferences and Their Physicians' Perceptions
	Elena B. Elkin, Susie H.M. Kim, Ephraim S. Casper, David W. Kissane, and Deborah Schrag
	JCO Nov 20 2007: 5275–5280. [Abstract] [Full Text] [PDF] [Data Supplement]

REVIEW ARTICLE
	Neoadjuvant Cisplatin Chemotherapy Before Chemoradiation: A Flawed Paradigm?
	Rob Glynne-Jones and Peter Hoskin
	JCO Nov 20 2007: 5281–5286. [Abstract] [Full Text] [PDF]

ASCO SPECIAL ARTICLES
	American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
	Lyndsay Harris, Herbert Fritsche, Robert Mennel, Larry Norton, Peter Ravdin, Sheila Taube, Mark R. Somerfield, Daniel F. Hayes, and Robert C. Bast, Jr
	JCO Nov 20 2007: 5287–5312. First published on Oct 22 2007; 10.1200/JCO.2007.14.2364. [Abstract] [Full Text] [PDF] [Polish PDF] [Chinese PDF] [Journal of Oncology Practice Summary]
	American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Nonhormonal Therapy for Men With Metastatic Hormone-Refractory (castration-resistant) Prostate Cancer
	Ethan M. Basch, Mark R. Somerfield, Tomasz M. Beer, Michael A. Carducci, Celestia S. Higano, Maha H.A. Hussain, and Howard I. Scher
	JCO Nov 20 2007: 5313–5318. First published on Oct 9 2007; 10.1200/JCO.2007.13.4536. [Abstract] [Full Text] [PDF] [Chinese PDF] [Publisher's Note]

DIAGNOSIS IN ONCOLOGY

Multiple Myeloma Presenting With [18F]Fluorodeoxyglucose Avid Liver Lesions Diagnosed on Positron Emission Tomography Scan

Munir Ghesani, Sumina Goel, Murali Meka, Seth Cohen, Angela Chang, and Peter Maslin

JCO Nov 20 2007: 5319–5320. [Full Text] [PDF] [Publisher's Note]

Reversible Posterior Leukoencephalopathy Syndrome Associated With Oxaliplatin

Daryl M. Pinedo, Farheen Shah-Khan, and Prabodh C. Shah

JCO Nov 20 2007: 5320–5321. [Full Text] [PDF]

Successful Antiangiogenic Therapy for Neuroblastoma With Thalidomide

Benjamin Gesundheit, Asher Moser, Reuven Or, and Giannoula Klement

JCO Nov 20 2007: 5321–5324. [Full Text] [PDF]

CORRESPONDENCE

Regarding the Influence of Adjuvant Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarction: How Real Is the Risk?

Mack Roach, III

JCO Nov 20 2007: 5325–5326. [Full Text] [PDF]

In Reply

Anthony V. D'Amico and Ming-Hui Chen

JCO Nov 20 2007: 5326. [Full Text] [PDF]

Oral Contraceptives and Breast Cancer Risk

Anca C. Ansink and Curt W. Burger

JCO Nov 20 2007: 5327. [Full Text] [PDF]

In Reply

Richard M. Brohet, Flora E. Van Leeuwen, Matti A. Rookus, David E. Goldgar, Douglas F. Easton, Antonis C. Antoniou, Nadine Andrieu, and Jenny Chang-Claude

JCO Nov 20 2007: 5327–5328. [Full Text] [PDF]

More Claims About Depression, Immune Function, and Survival That Exceed the Evidence

James C. Coyne and Steven C. Palmer

JCO Nov 20 2007: 5328–5329. [Full Text] [PDF]

In Reply

Jennifer L. Steel, T. Clark Gamblin, David A. Geller, Marion C. Olek, and Brian I. Carr

JCO Nov 20 2007: 5329–5331. [Full Text] [PDF]

The Value of Label Recommendations: How to Dose Lapatinib

Kevin M. Koch, Andrew P. Beelen, Peter T.C. Ho, and Debasish F. Roychowdhury

JCO Nov 20 2007: 5331–5332. [Full Text] [PDF]

Effect of Food on Lapatinib Pharmacokinetics

Andrea Messori

JCO Nov 20 2007: 5332–5333. [Full Text] [PDF]

Controversies in Using Lapatinib at Reduced Dosage With Food

Sabrina Trippoli

JCO Nov 20 2007: 5333. [Full Text] [PDF]

The Value Meal: Effect of Food on Lapatinib Bioavailability

Atiqur Rahman, Richard Pazdur, Yaning Wang, Shiew-Mei Huang, and Lawrence Lesko

JCO Nov 20 2007: 5333–5334. [Full Text] [PDF]

In Reply

Mark J. Ratain and Ezra E.W. Cohen

JCO Nov 20 2007: 5334–5335. [Full Text] [PDF]

Predicting the Risk of Pancreatic Cancer: On CDKN2A Mutations in the Melanoma-Pancreatic Cancer Syndrome in Italy

Paola Ghiorzo, Sara Gargiulo, Sabina Nasti, Lorenza Pastorino, Linda Battistuzzi, William Bruno, Luigina Bonelli, Paola Taveggia, Vittorio Pugliese, Giacomo Borgonovo, Luca Mastracci, Giuseppe Fornarini, Paola Romagnoli, Elena Iiritano, Vincenzo Savarino, and Giovanna Bianchi-Scarrà

JCO Nov 20 2007: 5336–5337. [Full Text] [PDF]

In Reply

Wenyi Wang, Sining Chen, Kieran A. Brune, Ralph H. Hruban, Giovanni Parmigiani, and Alison P. Klein

JCO Nov 20 2007: 5337–5338. [Full Text] [PDF]

ERRATA

ERRATA

JCO Nov 20 2007: 5339. [Full Text] [PDF]

ERRATA

JCO Nov 20 2007: 5339. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.